School of Medicine
Showing 1-8 of 8 Results
Michael P. Marks, MD
Professor of Radiology (General Radiology) and, by courtesy, of Neurosurgery
Current Research and Scholarly Interests Interventional neuroradiology; cerebral arteriovenous malformations; stroke treatment and imaging; cerebral aneurysms
Sr Res Scientist-Basic Life, Neurosurgery
Current Role at Stanford Senior Scientist.
Research Team leader, brain tumor and human neural stem cell research
Adult and Pediatric brain tumor CD47 therapeutic development group
Justin M Moore
Clinical Instructor, Neurosurgery
Bio Justin Moore completed B.Med.Sci and Medical degrees at Monash University in Melbourne, Australia under a faculty scholarship and obtained first class honors in both. Justin also completed a law degree with an emphasis on medical law. He completed his intern year and basic surgical training at St Vincent’s Hospital in Melbourne, Australia while obtaining a post-graduate diploma in surgical anatomy from Melbourne University. Justin was awarded a scholarship to Oxford University in the UK, where he completed a PhD in neuro-genomics, which focused on novel genes involve in neurodevelopment and tumor formation. Justin then returned to Australia and completed residency training in Neurosurgery, training at numerous hospitals including The Alfred, Monash and Royal Melbourne Hospitals before being awarded a fellowship of Royal Australasian College of Surgeons. He has just completed a cerebrovascular fellowship at BIDMC, Harvard Medical School in the USA. He has active research interests in cerebrovascular neurosurgery, neuro-oncology and the interaction between the law and neurosurgery.
Clinical Assistant Professor, Neurosurgery
Current Research and Scholarly Interests Dr. Murovic is a member of the Stanford University Medical Center (SUMC) CyberKnife Radiosurgery (CK RS) Treatment Center at the Stanford Cancer Center and at Blake Wilbur. She helps to co-ordinate the patients' CK RS treatments. She is also Co-Protocol Director of a new Stanford Cancer Center trial which is evaluating the outcomes of patients with 1-3 versus 4 or more brain tumor metastases after treatment with CK RS. She is currently preparing a chapter on the CK RS treatment of brain tumor metastases. In the Neurosurgery Spine laboratory she has been studying the incidence of spinal adjacent segment disease after traditional cervical fusions.